1. Home
  2. STRO vs VCIC Comparison

STRO vs VCIC Comparison

Compare STRO & VCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • VCIC
  • Stock Information
  • Founded
  • STRO 2003
  • VCIC 2024
  • Country
  • STRO United States
  • VCIC United States
  • Employees
  • STRO N/A
  • VCIC N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • VCIC
  • Sector
  • STRO Health Care
  • VCIC
  • Exchange
  • STRO Nasdaq
  • VCIC NYSE
  • Market Cap
  • STRO 292.6M
  • VCIC 293.0M
  • IPO Year
  • STRO 2018
  • VCIC 2024
  • Fundamental
  • Price
  • STRO $2.81
  • VCIC $10.01
  • Analyst Decision
  • STRO Strong Buy
  • VCIC
  • Analyst Count
  • STRO 7
  • VCIC 0
  • Target Price
  • STRO $12.14
  • VCIC N/A
  • AVG Volume (30 Days)
  • STRO 1.0M
  • VCIC 6.2K
  • Earning Date
  • STRO 11-13-2024
  • VCIC 01-01-0001
  • Dividend Yield
  • STRO N/A
  • VCIC N/A
  • EPS Growth
  • STRO N/A
  • VCIC N/A
  • EPS
  • STRO N/A
  • VCIC N/A
  • Revenue
  • STRO $160,955,000.00
  • VCIC N/A
  • Revenue This Year
  • STRO N/A
  • VCIC N/A
  • Revenue Next Year
  • STRO N/A
  • VCIC N/A
  • P/E Ratio
  • STRO N/A
  • VCIC N/A
  • Revenue Growth
  • STRO 230.90
  • VCIC N/A
  • 52 Week Low
  • STRO $2.45
  • VCIC $9.96
  • 52 Week High
  • STRO $6.13
  • VCIC $10.02
  • Technical
  • Relative Strength Index (RSI)
  • STRO 40.82
  • VCIC N/A
  • Support Level
  • STRO $2.66
  • VCIC N/A
  • Resistance Level
  • STRO $2.86
  • VCIC N/A
  • Average True Range (ATR)
  • STRO 0.17
  • VCIC 0.00
  • MACD
  • STRO 0.03
  • VCIC 0.00
  • Stochastic Oscillator
  • STRO 64.29
  • VCIC 0.00

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About VCIC VINE HILL CAP INVT CORP

Vine Hill Capital Investment Corp is a blank check company.

Share on Social Networks: